Patents

Description

INHIBITORI AI ADEZIUNII CELULARE

Price not visible for this package

Interest:

Assignment

Publication info:

No.: RO119885

Date: 30.05.2005

Inventor(s):

ADAMS STEVEN P [US]

LIN KO-CHUNG [US]

LEE WEN-CHERNG [US]

CASTRO ALFREDO C [US]

ZIMMERMAN CRAIG N [US]

HAMMOND CHARLES E [US]

LIAO YU SHENG [US]

CUERVO JULIO HERNAN [US]

SINGH JUSWINDER [US]

Applicant(s):
BIOGEN INC [US]
Classification:
International patent classification (IPC):
A61K31/195; A61K31/27; A61K31/275; A61K31/357; A61K31/36; A61K31/40; A61K31/4025; A61K31/403; A61K31/404; A61K31/42; A61K31/425; A61K31/426; A61K31/44; A61K31/443; A61P1/00; A61P11/00; A61P29/00; A61P3/00; A61P3/08; A61P37/00; A61P43/00; C07C237/22; C07C255/19; C07C271/22; C07C275/28; C07C275/42; C07C275/54; C07C311/06; C07C311/21; C07C317/50; C07C323/59; C07C323/60; C07D209/18; C07D209/42; C07D213/55; C07D213/75; C07D215/48; C07D277/20; C07D277/48; C07D277/56; C07D317/60; C07D405/12; C07D413/12; A61K31/00; A61K31/138
Cooperative patent classification (CPC):
A61P1/00 (EP); A61P11/00 (EP); A61P11/06 (EP); A61P17/06 (EP); A61P19/02 (EP); A61P25/00 (EP); A61P25/28 (EP); A61P29/00 (EP); A61P3/00 (EP); A61P3/08 (EP); A61P3/10 (EP); A61P37/00 (EP); A61P37/04 (EP); A61P37/06 (EP); A61P43/00 (EP); C07C237/22 (EP, KR, US); C07C255/19 (EP, US); C07C271/22 (EP, KR, US); C07C275/28 (EP, US); C07C275/38 (KR); C07C275/42 (EP, US); C07C275/54 (EP, US); C07C311/06 (EP, US); C07C311/21 (EP, US); C07C317/50 (EP, US); C07C323/60 (EP, US); C07D209/42 (EP, US); C07D213/55 (EP, US); C07D213/75 (EP, US); C07D215/48 (EP, US); C07D277/48 (EP, US); C07D317/60 (EP, US); C07D405/12 (EP, US); C07K7/06 (EP, US); A61K38/00 (EP, US); C07C2601/02 (EP, US); C07C2601/14 (EP, US)
Application info:
No.: RO19970001369
Date: 18.01.1996
Priority number(s):
US19950376372 23.01.1995 ; WO1996US01349 18.01.1996
Related patents:
ATE229498; AU4911596; AU718926; BG101841; BG63383; BR9606778; CA2211181; CN1177343; CN1192015; CZ234097; CZ291556; DE69625332; DK0805796; EA003320; EA199700135; EA200200844; EE04111; EE9700172; EP0805796; EP1142867; ES2183937; FI973087; HK1005241; HK1041477; HU223350; HU9702461; IL116846; JP2008013574; JP4129293; JPH10513160; KR100413328; KR19980701672; MX9705569; NO320914; NO973384; NZ336104; PL187313; PL321848; PT805796; SK283724; SK98797; TW500714; US2003018016; US2003083267; US2006166866; US6306840; US6376538; US6624152; US6630512; WO9622966
Description:

Prezenta invenţie se referă la compuşi inhibitori ai adeziunii celulare, la compoziţii farmaceutice care conţin aceşti compuşi, la utilizarea compoziţiilor farmaceutice la fabricarea unui medicament pentru prevenirea, inhibarea, sau suprimarea adeziunii celulare asociată cu inflamaţia, în special pentru prevenirea, inhibarea, sau suprimarea adeziunii celulare asociată cu răspunsul imun sau autoimun, precum şi pentru tratamentul sau prevenirea bolilor, cum ar fi astmul, artrita, psoriazisul, respingerea transplantului, scleroza multiplă, diabetul şi bolile inflamatorii. ŕ

Share this on:
Facebook Twitter/X LinkedIn Whatsapp Email